Review
Open access
Aug 2026
Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023–2026 evidence and a proposed clinical integration framework
A narrative review synthesizes evidence published between 2020 and 2026 within a unified clinical framework not provided by prior reviews, and proposes an original biomarker-guided clinical algorithm, a comparative clinical readiness table, and a disease-continuum biomarker timeline as practical tools for clinicians an...
Ashish Sharma, J. Tan, Rajvardhan Sisodia et al.
· Frontiers in Oncology · 0 citations